Resultados de la búsqueda 291-300 of 12711 for Polycythaemia vera

1. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

2. Hematología - Ensayos clínicos

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

3. Smoldering multiple myeloma (SMM) - Diagnósticos y tratamientos - Mayo Clinic

   Changed plasma cells making up 10% to less than 60% of the cells in the bone marrow. For a diagnosis of SMM, you also mush not have light-chain amyloidosis or a ...

4. Trombocitopenia inmunitaria - Médicos y departamentos - Mayo Clinic

   Polycythemia Vera: Just been diagnosed. 442 Replies Mon, Nov 17, 2025. See more discussions. Relacionado. Procedimientos asociados. Esplenectomía · Hemograma ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

6. Síndrome de POEMS - Médicos y departamentos - Mayo Clinic

   Polycythemia Vera: Just been diagnosed. 442 Replies Mon, Nov 17, 2025. Tracy · Has anyone been diagnosed with POEMS syndrome? 21 Replies Sun, Nov 16, 2025. See ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

8. Síndrome de POEMS - Médicos y departamentos - Mayo Clinic

   Polycythemia Vera: Just been diagnosed. 501 Replies Sat, Oct 10, 2026. Heather McFarland. A Summary of My Multiple Myeloma. 91 Replies Mon, Oct 05, 2026. zenk.

9. Hematología - Ensayos clínicos - Mayo Clinic

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...